Cargando…
Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice
The destruction of beta cells in type 1 diabetes (T1D) results in loss of insulin production and glucose homeostasis. Treatment of non-obese diabetic (NOD) mice with immune-depleting/modulating agents (e.g., anti-CD3, murine anti-thymocyte-globulin (mATG)) can lead to diabetes reversal. However, for...
Autores principales: | Gagliani, Nicola, Jofra, Tatiana, Posgai, Amanda L., Atkinson, Mark A., Battaglia, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651367/ https://www.ncbi.nlm.nih.gov/pubmed/26580221 http://dx.doi.org/10.1371/journal.pone.0142318 |
Ejemplares similares
-
Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant
por: Gagliani, Nicola, et al.
Publicado: (2010) -
Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice
por: Valle, Andrea, et al.
Publicado: (2009) -
Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation
por: Gagliani, Nicola, et al.
Publicado: (2011) -
Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
por: Xue, Song, et al.
Publicado: (2015) -
Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice
por: Fousteri, Georgia, et al.
Publicado: (2015)